|
Subject id: (b)(6) study no: (b)(6) clinical adverse event received for failure of left total knee arthroplasty.Loosening of tibial and femoral components.Meddra code - 10021539 device related: definitely related procedure related: possibly related date of event: (b)(6) 2024 date of implant: (b)(6) 2013 date of revision: (b)(6) 2024 device location: left treatment/impact: requires in patient hospitalization, results in a medical or surgical intervention to prevent life-threatening illness or injury or permanent impairment to a body structure or function, medical intervention/modification, revision of left total knee arthroplasty, components removed: femoral component, tibial base, tibial insert, and patellar component (for previously resurfaced patella).
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional narrative: h3, h6: the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.No device associated with this report was received for examination.The product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A records evaluation (mre) was not perform as part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.
|